Amelia Kellar
Overview
Explore the profile of Amelia Kellar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kellar A, Dolinger M, Spencer E, Dubinsky M
Dig Dis Sci
. 2024 Mar;
69(5):1826-1833.
PMID: 38521850
Background: Data are limited on the safety and efficacy of combining advanced therapies for refractory patients with IBD. Aim: To evaluate the real-world efficacy and safety of dual advanced therapy...
2.
Krugliak Cleveland N, St-Pierre J, Kellar A, Rubin D
Curr Gastroenterol Rep
. 2024 Jan;
26(2):31-40.
PMID: 38243153
Purpose Of Review: Intestinal ultrasound (IUS) is a non-invasive, accurate, and well-tolerated tool that provides real-time assessment of inflammatory bowel disease (IBD) activity and is therefore an ideal monitoring tool....
3.
Dolinger M, Aronskyy I, Kellar A, Spencer E, Pittman N, Dubinsky M
J Crohns Colitis
. 2023 Dec;
18(7):1002-1011.
PMID: 38141229
Background And Aims: STRIDE-II recommends early biomarker targets for treatment optimization to achieve treat-to-target [T2T] endoscopic remission [ER] in Crohn's disease [CD]. The predictive capabilities of intestinal ultrasound [IUS] for...
4.
Spencer E, Bergstein S, Dolinger M, Pittman N, Kellar A, Dunkin D, et al.
Inflamm Bowel Dis
. 2023 Dec;
30(11):2057-2063.
PMID: 38134405
Background: Upadacitinib (UPA) is a novel selective JAK inhibitor approved for adults with ulcerative colitis (UC) and with positive phase 3 data for Crohn's disease (CD). Pediatric off-label use is...
5.
Dolinger M, Aronskyy I, Kellar A, Gao M, Spencer E, Pittman N, et al.
Am J Gastroenterol
. 2023 Dec;
119(5):930-936.
PMID: 38131626
Introduction: High rates of screen failure for the minimum Simple Endoscopic Score for Crohn's Disease (SES-CD) plague Crohn's disease (CD) clinical trials. We aimed to determine the accuracy of segmental...
6.
Dolinger M, Kellar A
Curr Gastroenterol Rep
. 2023 Aug;
25(11):355-361.
PMID: 37624558
Purpose Of Review: Intestinal ultrasound (IUS) is an emerging non-invasive point-of-care tool utilized by pediatric gastroenterologists for accurately detecting and monitoring inflammatory bowel disease (IBD) activity. In this article, we...
7.
Kellar A, Dolinger M, Novak K, Chavannes M, Dubinsky M, Huynh H
J Pediatr Gastroenterol Nutr
. 2022 Oct;
76(2):142-148.
PMID: 36306530
Crohn disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) often diagnosed in childhood. A strict monitoring strategy can potentially alter the disease course and facilitate early effective treatment...
8.
Hart-Matyas M, Foong E, Kellar A, Li L, Au H
Pediatr Rev
. 2021 Jan;
42(1):38-40.
PMID: 33386304
No abstract available.
9.
Kellar A, Wilson S, Kaplan G, DeBruyn J, Tanyingoh D, Novak K
J Pediatr Gastroenterol Nutr
. 2019 Jun;
69(1):e1-e6.
PMID: 31232886
Objective: The aim of the study was to identify the most significant ultrasound (US) parameters that predict inflammatory activity and develop a simple US activity score. Methods: Patients were identified...
10.
Kellar A, Tangtatco J, Weinstein M, Saunders N
J Cutan Med Surg
. 2017 Sep;
22(2):223-225.
PMID: 28934873
Subcutaneous fat necrosis of the newborn (SFNN) is a rare disorder characterised by indurated plaques or nodules with or without erythema, typically distributed over the cheeks, extremities, posterior trunk, buttocks,...